Preclinical PK/PD model for combined administration of erlotinib and sunitinib in the treatment of A549 human NSCLC xenograft mice
Crossref DOI link: https://doi.org/10.1038/aps.2016.55
Published Online: 2016-05-16
Published Print: 2016-07
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Li, Jing-yun
Ren, Yu-peng
Yuan, Yin
Ji, Shuang-min
Zhou, Shu-pei
Wang, Li-jie
Mou, Zhen-zhen
Li, Liang
Lu, Wei
Zhou, Tian-yan
Text and Data Mining valid from 2016-05-16
Article History
Received: 27 August 2015
Accepted: 24 January 2016
First Online: 16 May 2016